Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.90 USD
Change Today -5.50 / -8.16%
Volume 1.5M
LCI On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 4:15 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur P. Bedrosian J.D.

Chief Executive Officer, Director and Chairman of Strategic Planning Committee, Lannett Company, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 1 different industries.

See Board Relationships
69$3,134,061
As of Fiscal Year 2014

Background*

Mr. Arthur P. Bedrosian, J.D. has been the Chief Executive Officer at Lannett Company, Inc. since January 3, 2006 and served as its President from May 2002 to December 1, 2014. Mr. Bedrosian served as the Vice President of Business development at Lannett Co Inc. from January 2002 to April 2002, and as a Director from February 2000 to January 2002. Mr. Bedrosian has operated generic drug manufacturing, sales, and marketing businesses in the healthcare industry for over ...

Read Full Background

Corporate Headquarters*

9000 State Road
Philadelphia, Pennsylvania 19136

United States

Phone: 215-333-9000
Fax: --

Board Members Memberships*

2006-Present
Chief Executive Officer, Director and Chairman of Strategic Planning Committee

Education*

BA
Queens College
JD
Janus University

Other Affiliations*

Annual Compensation*

Salary$539,000
Total Annual Compensation$539,000

Stock Options*

Restricted Stock Awards$995,450
All Other Compensation$64,286
Exercised Options30,000
Exercised Options Value$842,100
Exercisable Options315,999
Exercisable Options Value$14,065,861
Unexercisable Options162,501
Unexercisable Options Value$6,532,494
Total Value of Options$21,440,455
Total Number of Options508,500

Total Compensation*

Total Annual Cash Compensation$1,411,786
Total Short Term Compensation$539,000
Other Long Term Compensation$1,059,736
Total Calculated Compensation$3,134,061
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $61.90 USD -5.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Samuel M. Inman IIIChairman, Chief Executive Officer and President
Covisint Corporation
$23.2K
Dhananjaya Alii Managing Director and Executive Director
Vista Pharmaceuticals Limited
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.